Arkolith/Insider Trading/CMPI/Form 4

Fuhrman Alan

See Remarks, DirectorCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed Oct 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 27, 2021Grant(A)247K—$0247K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-042072) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML